IL160030A0 - Treatment of muscular dystrophy with cord blood cells - Google Patents

Treatment of muscular dystrophy with cord blood cells

Info

Publication number
IL160030A0
IL160030A0 IL16003002A IL16003002A IL160030A0 IL 160030 A0 IL160030 A0 IL 160030A0 IL 16003002 A IL16003002 A IL 16003002A IL 16003002 A IL16003002 A IL 16003002A IL 160030 A0 IL160030 A0 IL 160030A0
Authority
IL
Israel
Prior art keywords
treatment
blood cells
cord blood
muscular dystrophy
dystrophy
Prior art date
Application number
IL16003002A
Other languages
English (en)
Original Assignee
Viacell Inc
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viacell Inc, Gen Hospital Corp filed Critical Viacell Inc
Publication of IL160030A0 publication Critical patent/IL160030A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16003002A 2001-07-23 2002-07-23 Treatment of muscular dystrophy with cord blood cells IL160030A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30722701P 2001-07-23 2001-07-23
PCT/US2002/023368 WO2003009857A1 (en) 2001-07-23 2002-07-23 Treatment of muscular dystrophy with cord blood cells

Publications (1)

Publication Number Publication Date
IL160030A0 true IL160030A0 (en) 2004-06-20

Family

ID=23188804

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16003002A IL160030A0 (en) 2001-07-23 2002-07-23 Treatment of muscular dystrophy with cord blood cells

Country Status (10)

Country Link
US (2) US7452529B2 (xx)
EP (1) EP1411957A1 (xx)
JP (1) JP2004536139A (xx)
CN (1) CN1638783A (xx)
BR (1) BR0211400A (xx)
CA (1) CA2455726A1 (xx)
HU (1) HUP0501108A3 (xx)
IL (1) IL160030A0 (xx)
PL (1) PL367979A1 (xx)
WO (1) WO2003009857A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070298015A1 (en) * 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
WO2005120526A1 (ja) * 2004-06-11 2005-12-22 Combi Corporation 筋ジストロフィー進行抑制組成物
WO2008137115A1 (en) 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
CN104212760B (zh) * 2013-05-29 2017-08-08 中国科学院上海生命科学研究院 肌肉干细胞体外培养方法及其应用
JP6401445B2 (ja) * 2013-10-10 2018-10-10 国立大学法人 東京大学 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法
US9617506B2 (en) 2013-11-16 2017-04-11 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3613841B1 (en) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passive replacement of media
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2016201182A1 (en) 2015-06-11 2016-12-15 The Board Of Trustees Of The University Of Illinios Muscular dystrophy chimeric cells and method for treating muscular dystrophies
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11702634B2 (en) 2017-03-31 2023-07-18 Terumo Bct, Inc. Expanding cells in a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925567A (en) 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US5674750A (en) 1995-05-19 1997-10-07 T. Breeders Continuous selective clonogenic expansion of relatively undifferentiated cells
WO1999037751A1 (en) * 1998-01-23 1999-07-29 Imclone Systems Incorporated Purified populations of stem cells
US20020051762A1 (en) 1998-01-23 2002-05-02 Shahin Rafii Purified populations of endothelial progenitor cells

Also Published As

Publication number Publication date
HUP0501108A2 (en) 2006-04-28
CA2455726A1 (en) 2003-02-06
US20090068156A1 (en) 2009-03-12
EP1411957A1 (en) 2004-04-28
JP2004536139A (ja) 2004-12-02
WO2003009857A8 (en) 2003-12-24
US7452529B2 (en) 2008-11-18
US20030118565A1 (en) 2003-06-26
WO2003009857A1 (en) 2003-02-06
BR0211400A (pt) 2004-11-09
HUP0501108A3 (en) 2006-11-28
CN1638783A (zh) 2005-07-13
PL367979A1 (en) 2005-03-21

Similar Documents

Publication Publication Date Title
EP1401557A4 (en) OXYGEN MEDICAL CONCENTRATOR
HUP0501108A3 (en) Treatment of muscular dystrophy with cord blood cells
IL159816A0 (en) In-vivo method and device for improving diastolic function of the left ventricle
IL158618A0 (en) Biological pacemaker
IL166171A0 (en) Blood clot-targeted nanoparticles
IL218909A0 (en) Treatment of diabetes
GB2393202B (en) Methods of well treatment
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
AU2002357830A1 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
GB0201674D0 (en) Medical treatment
CA97619S (en) Cardiac electrode
CA97620S (en) Medical electrode
GB0218879D0 (en) Medical treatment
AU2003219462A1 (en) Defibrillator/monitor with patient specific treatment algorithms
AU2003298664A1 (en) Treatment of cognitive dysfunctions'
LU91070B1 (en) Treatment and diagnosis of insulin resistant states
EP1435962A4 (en) TREATMENT OF DIABETES TYPE I
IL164951A0 (en) The treatment of pain with lfendropil
GB0300428D0 (en) Medical treatment
AU2003238227A1 (en) Treatment of blood with light
AU2002345895A1 (en) Medical oxygen concentrator
GB0211515D0 (en) Blood treatment
AU2002223718A1 (en) Analysis of longevity of patient treatment object
GB0127267D0 (en) Medical treatment
GB0220849D0 (en) Medical treatment